Titelia

Fund shareholders of Perspective Therapeutics Inc

ISIN US46489V3024 · United States · LEI 5493005LRKM6BCABC605

Fund shareholders
118
Of which ETFs
23 95 other funds
Value held
69M $
Share of capital
17.8 % of 114.2M shares on Aug 5, 2026
FundSharesValueWeight in fundShare of capital
VIP Total Market Index Portfolio Variable Insurance Products Fund II 2,0967.1K $0.00 %0.00 %as of Jun 30, 2026 ↗
Total Stock Market Index Trust John Hancock Variable Insurance Trust 1,9036.5K $0.00 %0.00 %as of Jun 30, 2026 ↗
Pacer WealthShield ETF Pacer Funds Trust 1,8745.5K $0.02 %0.00 %as of Jul 31, 2026 ↗
Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust 1,8507.3K $0.00 %0.00 %as of May 31, 2026 ↗
ULTRA SMALL CAP PROFUND ProFunds 1,3293.9K $0.01 %0.00 %as of Jul 31, 2026 ↗
Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III 5821.7K $0.00 %0.00 %as of Jul 31, 2026 ↗
Russell 2000 2x Strategy Fund Rydex Dynamic Funds 5551.9K $0.00 %0.00 %as of Jun 30, 2026 ↗
State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST 4431.5K $0.00 %0.00 %as of Jun 30, 2026 ↗
PROFUND VP ULTRA SMALL CAP ProFunds 4241.4K $0.01 %0.00 %as of Jun 30, 2026 ↗
TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 282961.6 $0.00 %0.00 %as of Jun 30, 2026 ↗
PROFUND VP SMALL CAP ProFunds 277944.6 $0.01 %0.00 %as of Jun 30, 2026 ↗
Russell 2000 Fund Rydex Series Funds 256873 $0.01 %0.00 %as of Jun 30, 2026 ↗
Russell 2000 1.5x Strategy Fund Rydex Series Funds 153521.7 $0.01 %0.00 %as of Jun 30, 2026 ↗
Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I 105358.1 $0.01 %0.00 %as of Jun 30, 2026 ↗
SMALL-CAP PROFUND ProFunds 87253.2 $0.00 %0.00 %as of Jul 31, 2026 ↗
ProShares Hedge Replication ETF ProShares Trust 58228.5 $0.00 %0.00 %as of May 31, 2026 ↗
Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust 2998.9 $0.00 %0.00 %as of Jun 30, 2026 ↗
ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust 1870.9 $0.01 %0.00 %as of May 31, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
Voya MI Dynamic Small Cap Fund Voya Equity Trust 0.22 %as of May 31, 2026 ↗
VOYA SMALL COMPANY PORTFOLIO Voya VARIABLE PORTFOLIOS INC 0.18 %as of Jun 30, 2026 ↗
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST 0.13 %as of Jun 30, 2026 ↗
PROFUND VP BIOTECHNOLOGY ProFunds 0.13 %as of Jun 30, 2026 ↗
Ultra-Small Company Market Fund Bridgeway Funds, Inc. 0.12 %as of Jun 30, 2026 ↗
BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds 0.09 %as of Jul 31, 2026 ↗
Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust 0.08 %as of Jul 31, 2026 ↗
iShares Micro-Cap ETF iShares Trust 0.08 %as of Jun 30, 2026 ↗
Federated Hermes MDT Small Cap Growth Fund Federated Hermes MDT Series 0.07 %as of Jul 31, 2026 ↗
BlackRock Advantage SMID Cap V.I. Fund BlackRock Variable Series Funds, Inc. 0.04 %as of Jun 30, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterShareholdersChangeSharesChange
2026Q3118+1120,339,668+44.9 %
2026Q2107+514,037,436+38.6 %
2026Q1102-810,126,247-33.9 %
2025Q4110+115,329,903-12.0 %
2025Q3109-1117,415,695+0.7 %
2025Q2120-117,298,646+1.1 %
2025Q1121-417,108,866+0.4 %
2024Q4125+8317,042,286+244.4 %
2024Q3424,948,653

Institutional managers

131 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.

ManagerSharesValue
TCG Crossover Management, LLC7,915,56733M $as of Mar 31, 2026
Commodore Capital LP6,336,78226.4M $as of Mar 31, 2026
Avidity Partners Management LP6,049,99925.2M $as of Mar 31, 2026
BlackRock, Inc.5,348,56122.3M $as of Mar 31, 2026
Opaleye Management Inc.4,675,00019.5M $as of Mar 31, 2026
MILLENNIUM MANAGEMENT LLC4,046,64016.9M $as of Mar 31, 2026
CITADEL ADVISORS LLC3,566,50414.9M $as of Mar 31, 2026
Affinity Asset Advisors, LLC3,164,58213.2M $as of Mar 31, 2026
STATE STREET CORP3,132,67013.1M $as of Mar 31, 2026
Balyasny Asset Management L.P.2,994,46012.5M $as of Mar 31, 2026
MORGAN STANLEY2,983,34212.4M $as of Mar 31, 2026
Spruce Street Capital LP2,627,10711M $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC1,766,9607.4M $as of Mar 31, 2026
Patient Square Capital LP1,625,0006.8M $as of Mar 31, 2026
Nicholson Wealth Management Group, LLC1,618,9936.8M $as of Mar 31, 2026
GOLDMAN SACHS GROUP INC1,241,8165.2M $as of Mar 31, 2026
Yu Fan1,055,4094.4M $as of Mar 31, 2026
TWO SIGMA INVESTMENTS, LP1,003,4744.2M $as of Mar 31, 2026
Ally Bridge Group (NY) LLC926,5573.9M $as of Mar 31, 2026
Nuveen, LLC910,2213.8M $as of Mar 31, 2026
Hills Bank & Trust Co872,2003.6M $as of Mar 31, 2026
Octagon Capital Advisors LP791,5553.3M $as of Mar 31, 2026
ADAR1 Capital Management, LLC749,3353.1M $as of Mar 31, 2026
CHARLES SCHWAB INVESTMENT MANAGEMENT INC661,3182.8M $as of Mar 31, 2026
NORTHERN TRUST CORP528,9282.2M $as of Mar 31, 2026

Declared shareholders of Perspective Therapeutics Inc

There are 5 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.

ShareholderDeclared stakeShares
Lantheus Holdings, Inc. and 2 others7.70 %8,739,011as of Sep 21, 2026 · SCHEDULE 13D
BlackRock, Inc. 6.80 %7,776,940as of Jun 30, 2026 · SCHEDULE 13G
Integrated Core Strategies (US) LLC and 3 others5.50 %6,316,545as of Aug 7, 2026 · SCHEDULE 13G
Millennium Management LLC and 2 others5.30 %6,036,999as of Jul 13, 2026 · SCHEDULE 13G
STATE STREET CORPORATION 5.30 %6,051,771as of Jun 30, 2026 · SCHEDULE 13G
Cite this page

Titelia. "Fund shareholders of Perspective Therapeutics Inc". https://titelia.com/en/stocks/perspective-therapeutics-inc-US46489V3024